Kuehn Law investigates Travere Therapeutics officers and directors for potential fiduciary breaches

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Kuehn Law, PLLC is investigating whether certain officers and directors of Travere Therapeutics, Inc. breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing, and shareholders may be entitled to damages and corporate governance reforms. Long-term TVTX stockholders are encouraged to contact Justin Kuehn, Esq. at justin@kuehn.law or (833) 672-0814 for a free consultation with no obligation, as the law firm pays all case costs and does not charge investor clients. Shareholders are urged to act promptly because there may be limited time to enforce their rights.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
Travere Therapeutics Inc
TVTX
▼ NegativeRegulationrelevance

Investigation for potential fiduciary breaches and self-dealing by officers and directors